Drawing for BIOPHARMASPEC

USPTO serial 79154693

BIOPHARMASPEC

Reviewed by CopyMark Law Group

Reg. 4801698Status 706Registered
Filing date
Status date
Registration date
Sep 1, 2015
Examiner
LEE, YATSYE ISADORA
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with BIOPHARMASPEC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Hara K. Jacobs

Hara K. Jacobs Ballard Spahr LLP1735 Market Street, 51st FloorPhiladelphia, PA 19103-7599United States

Goods and services

ClassDescriptionStatusFirst use
041Educational, training and instructional services in the nature of courses, seminars, tutorials, conferences and workshops in the field of scientific research and analysis; providing education and training services, namely, training courses, seminars, tutorials, conferences and workshops on scientific analysis and analytical techniques; production of sound and video recordings in the field of scientific research and analysis for training purposes; publication of training manuals and educational, instructional and teaching materials; publication of scientific reports and texts; providing online electronic publications, namely, electronic books and journals in the field of scientific research and analysis; information, advisory and consultancy services relating to all of the aforesaid servicesACTIVE—
042Scientific research and development services; scientific analytical services, namely, chemical and biochemical analysis services for scientific research purposes; scientific analysis of materials and substances; development of scientific analytical methods; pharmaceutical, biopharmaceutical and biotechnological discovery, research and development services; pharmacokinetics research and development services; pre-clinical analytical testing services; laboratory services for analytical testing; bacteria testing and analysis services; sample testing and analysis services; mass spectrometry services; chromatography services; protein and glycoprotein analysis and sequencing; carbohydrate analysis and sequencing; gas phase sequencing; gel electrophoresis analysis; SEC MALLS analysis Size Exclusion Chromatography (SEC) with Multi-Angle Laser-Light Scattering-protein aggregation analysis; amino acid and sugar composition analysis; protein aggregation analysis; scientific research involving structural characterization of biopolymers, small molecule drugs and metabolites; compilation and provision of scientific data in the field of chemistry and biochemistry for research purposes; scientific data interpretation services, namely, scientific analysis in the field of chemistry and biochemistry; preparation and provision of scientific reports, namely, providing scientific information in the fields of chemistry and biochemistry; provision of certificates of analysis, namely, for the purpose of certifying the results of scientific analysis; design of computer software or computer programs for scientific or analytical applications; providing temporary use of on-line, non-downloadable software for automated presentation and interpretation of scientific data; information, advisory and consultancy services relating to all of the aforesaid servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 5, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jun 5, 202571AGREGISTERED-SEC.71 ACCEPTED—
Jun 2, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 11, 2025ES71TEAS SECTION 71 RECEIVED—
Sep 1, 2024REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Feb 23, 2024RNWLINTERNATIONAL REGISTRATION RENEWED—
Feb 7, 2022NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Feb 7, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 7, 2022PRANPOST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED—
Feb 7, 2022C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Feb 2, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 20, 2021ES75TEAS SECTION 71 & 15 RECEIVED—
Sep 1, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 3, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 13, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 27, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 27, 2016FIMPFINAL DISPOSITION PROCESSED—
Dec 1, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Sep 1, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 16, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 16, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 27, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 12, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 12, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 15, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 15, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 14, 2015ALIEASSIGNED TO LIE—
Apr 9, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 2, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 2, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 12, 2014RFNTREFUSAL PROCESSED BY IB—
Nov 24, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 24, 2014RFRRREFUSAL PROCESSED BY MPU—
Nov 21, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 20, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 18, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 14, 2014DOCKASSIGNED TO EXAMINER—
Nov 14, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 13, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance